The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares
Published 2111 days ago
Fraud Origo Partners (OPP) is one of the few remaining stocks of our AIM-China Filthy Forty. One might wonder if there is hope given that it is still here but Chairman John Chapman has offered up its FY18 accounts which are truly dreadful (again) and his chairman’s letter is pretty explicit as to why. In short, Origo shows everything that is wrong with AIM: the transfer of wealth from the many (shareholders) to the few. Read it and weep Marcus Stuttard, the head of AIM and Sham Sheriff – this is your system.
Published 1891 days ago
One can only have sympathy for John Chapman, the chairman of AIM-China Filthy Forty play Origo (OPP), who came in after the damage had been done by previous management and leaving a hospital pass for whoever followed. The full horror of what Mr Chapman inherited is detailed here in the FY18 Annual Report and this morning the bad news was that Origo’s investment (and I use the term in its loosest sense) had suffered another setback as a purported bidder (unidentified!) had apparently walked in the face of a demand for arbitration being served. Given that this was about the only asset of measurable (but questionable) value, Origo shares have slumped...
Published 329 days ago
I really do not wish to get on the wrong side of FemiNazi PR bird Ms. Sarah MacLeod but, with a hat tip to Evil Banksta, I must warn her that her client Celadon Pharmaceuticals (CEL) seems to have rather over-egged news of new contract wins ahead of bailout placings last year. So here is the timeline that Ms. MacLeod, and the Oxymorons at AIM Regulation should be looking at:Published 240 days ago
What has emerged today at Celadon Pharmaceuticals (CEL) is truly shocking even by the tawdry standards of the AIM sewer. The breaches of AIM Rules are explicit and clear. There is almost certainly a Companies Act breach as well and the Nomad has been grossly negligent. If heads do not roll you just have to ask what is the point of Marcus Stuttard and his team of Oxymorons at AIM regulation. I have dropped Marcus and his troops a letter, just to put them on notice.Published 234 days ago
Here are the most read articles and the most listened-to Bearcasts over the past seven days. The most read non-Tom article last week is by Steve Moore, with Accesso Technology – notes sales pipeline “which will benefit the group in subsequent years”, but to what extent and what about this year?!… at No 3 or No 13 including Bearcasts.
Published 240 days ago
The femiNazi PR to Celadon Pharmaceuticals (CEL) Sarah McLeod described my initial expose as “ your daily hit job” without actually reading the piece as she was busy lunching with other FemiNazis. I do hope that folks heeded that hit job and many others that followed because today the company has ‘fessed to a financial crisis and inadvertently admitted to a mammoth breach of AIM Rules 10 and 11. Its shares are surely uninvestable and really should be suspended for all sorts of reasons.Published 538 days ago
I really do hope that in penning this piece I am not going to interrupt another feminazi lunch being attended by Celadon Pharmaceuticals (CEL) PR head honcho Ms. Sarah McLeod. For I fear that Ms McLeod needs to stop discussing the gender pay gap and ensure her client – a company I have oft warned is drowning in red flags – to issue a statement as its share price continues to tumble. Here's why?Published 271 days ago
As it is Friday, I fear that FemiNazi PR Sarah Mcleod may be on a long lunch with the sisterhood but I suggest that with shares in her client Celadon Pharmaceuticals (CEL) diving again today to a new low of just 59p she should be crafting a statement. My money is on Celadon already knowing that forecasts will be missed and it needs to ‘fess up to that.Published 21 days ago
Oh dear, oh dear as disgraced ex tipster Mike Walters used to say as yet another of his share tips went disastrously wrong. And Celadon Pharmaceuticals (CEL) is exactly the sort of POS that Mike would love to have tipped. It announces contracts with a vast top line number but the sales never arrive, profits are a pipe dream and as for cash being generated, forget it. The management are obvious knaves who do not give a FF about listing disclosure rules and the financing of the enterprise is, to say the least, opaque.Published 142 days ago
If AIM was not such a joke then James Short, the CEO of Celadon Pharmaceuticals (CEL) would have been fired months ago for his tardy disclosure that sums owed from a May loan and equity investment agreement did not arrive on schedule. And they have still not arrived leaving the company in crisis, as it ‘fessed up to today.Published 243 days ago
Feminazi PR genius Sarah McLeod is a crafty old coot. Her client Celadon (CEL) announced a new US order a few months ago but neglected to mention its value. How careless. Meanwhile other contracts are said to have a “maximum value of x”. Again no hard numbers on what is actually expected. I have flagged up before how this company has overegged the pudding on revenue forecasts.Published 1067 days ago
A note out on 26th April 2022 from AIM-listed Origo Partners (OPP)updated its long suffering followers that its shares would be suspended from the month end, as its Nomad, Arden Partners, was being acquired and was giving up on the Nomad business. But since the asset disposal programme was almost finished, the company advised that it was not looking for a replacement. So as of 30 May 2022 Origo’s career of the AIM Casino will be history.
Published 330 days ago
The FemiNazi PR woman for Celadon Pharmaceuticals (CEL), Ms. Sarah MacLeod, has spun recent events well but in the end a turd, however polished, is still a turd. Welcome to calendar 2023 results which are atrocious.Published 544 days ago
The last time I warned folks about Celadon (CEL) its PR woman Sarah McLeod called to complain bitterly that I had ruined some feminazi lunch she’d been attending with what she termed my “daily hit job.” She then demanded free access to the site not having actually read the article or having any idea what I write on a daily business. Well Ms. McLeod GOTCHA. As predicted your client has had to pass the hat around. It may not now be existing on vapours but its valuation is still tonto.Published 6 hours ago
Last Friday I wrote to the Oxymorons at AIM Regulation flagging up an expose published that day about Nicole Patricia Gallois who was lined up to lend Celadon (CEL) though she had not actually ponied up but had taken a charge over all its assets – Nicole, I revealed HERE was dodgy as hell.Published 139 days ago
As a long term bear the near death throes of Celadon Pharmaceuticals (CEL) provide some morbid satisfaction but there is a way of, at least postponing, the grim end and that is a placing. It will be massively discounted but Celadon needs to come clean, fess up and do it before it’s too late.Published 747 days ago
Just as I highlighted yesterday HERE, all the reasons why Celadon Pharmaceuticals (CEL) was ludicrously overpriced, a co conspirator was one of hundreds if not thousands of folks receiving a whatsapp message on the very same company, a mass spamming by the disgraced John Story. Remember him?Published 8 days ago
“Oh dear, oh dear” as disgraced ex tipster Mike Walters would say when yet another of his share tips went horribly Pete Tong. No money, guzzling cash, likely to delist, a blue sky jam tomorrow story and run by rule breaking shysters, Celadon Pharmaceuticals (CEL) is just the sort of dog Walters would have tipped. Yesterday it waited until I was on the school run for its latest bad news. The shares, 125p two years ago when I first called this out, are now 3.5p.Published 123 days ago
On Friday, with the shares at 16p, Celadon Pharmaceuticals (CEL) announced that a punter wo had welshed on a May commitment to subscribe for shares at 105p had finally coughed up his final £150,000. But did he?Published 240 days ago
I have already demonstrated how, near as damn it bankrupt, Celadon Pharmaceuticals (CEL) breached AIM Rules in a grotesque way relating to its perilous financial position HERE. But it gets worse. A clued up bird has been on the dog and bone and I suggest that there are 4thgere are 4 additional matters that AIM Regulation must consider as a matter of urgency
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Thursday »
Wednesday »
Tuesday »
Monday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Thursday »
Wednesday »
Tuesday »
Monday »
Time left: 11:22:48
